Results from the largest report ever on young hairy cell leukemia (HCL) patients treated with standard chemotherapy — cladribine — are a mixed bag. On the one hand, a majority of the 83 patients, all ...
CURE attended the Hairy Cell Leukemia Foundation 2025 Conference where medical experts gathered to discuss advances in research and patient care. CURE had the privilege of attending the Hairy Cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results